AERIE PHARMACEUTICALS INC Annual Net Cash Provided by (Used in) Financing Activities in USD from 2014 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Aerie Pharmaceuticals Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2014 to 2021.
  • Aerie Pharmaceuticals Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was -$357K, a 67.6% increase year-over-year.
  • Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2021 was $2.97M.
  • Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2020 was -$859K, a 100% decline from 2019.
  • Aerie Pharmaceuticals Inc annual Net Cash Provided by (Used in) Financing Activities for 2019 was $275M, a 101% increase from 2018.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $2.97M +$3.83M Jan 1, 2021 Dec 31, 2021 10-K 2022-02-25
2020 -$859K -$276M -100% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-25
2019 $275M +$138M +101% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $137M +$1.39M +1.03% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $136M -$33M -19.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-24
2016 $169M +$117M +225% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $51.8M -$71.1M -57.8% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $123M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.